Commonly used as part of a training or active lifestyle routine
Regular physical activity stimulates intestinal motility and promotes regular bowel movements
The American Diabetes Association (ADA) recommends GLP-1 receptor agonists with proven cardiovascular benefit as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk
Systemic and Immune Symptoms Fatigue Chills or mild fever Muscle and joint aches Night sweats Flu-like feelings 4
We guide you through gentle movement and strengthening protocols to restore mobility and function safely
In several RCTs, GLP-1RAs, when used alone or in combination with other hypoglycemic agents including metformin, sulfonylurea, DPP-4 inhibitor, thiazolidinedione, and sodium-glucose cotransporter 2 inhibitor, showed superior or non-inferior blood glucose lowering ability compared to insulin treatment [64,65]